Search research articles
Contact Us
Filters
Showing results (1041-1050 of 1,063) with videos related to
Page
of 107
Sort By:
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity
Iyassu K Sebhat, Christopher Franklin, Michael M-C Lo, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 2, 2010
Antiobesity effect of MK-5046, a novel bombesin receptor subtype-3 agonist
Xiao-Ming Guan, Joseph M Metzger, Liming Yang, et al.
Archives of General Psychiatry
|
November 9, 2011
Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial
Roger D Weiss, Jennifer Sharpe Potter, David A Fiellin, et al.
Stem Cell Reports
|
November 10, 2015
Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem Cells
Zita Garate, Oscar Quintana-Bustamante, Ana M Crane, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 29, 2010
Biaryl substituted hydantoin compounds as TACE inhibitors
Wensheng Yu, Ling Tong, Seong Heon Kim, et al.
Plos One
|
October 21, 2017
GPR40 partial agonists and AgoPAMs: Differentiating effects on glucose and hormonal secretions in the rodent
Michele J Pachanski, Melissa E Kirkland, Daniel T Kosinski, et al.
American Journal of Obstetrics and Gynecology
|
June 5, 2021
Experience of 300 cases of prenatal fetoscopic open spina bifida repair: report of the International Fetoscopic Neural Tube Defect Repair Consortium
Magdalena Sanz Cortes, Ramen H Chmait, Denise A Lapa, et al.
Lancet (London, England)
|
March 24, 2009
Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials
Mark A Hlatky, Derek B Boothroyd, Dena M Bravata, et al.
JAMA Internal Medicine
|
April 13, 2026
Palliative Care Intervention for Patients With End-Stage Liver Disease: A Cluster Randomized Clinical Trial
Manisha Verma, Victor Navarro, Andrzej Kosinski, et al.
Journal of Medicinal Chemistry
|
July 25, 2025
Discovery of Gut-Targeted GPR40 Agonist K-757 and GPR119 Agonist K-833, a Combination Treatment for Metabolic Disorders
Christopher R Moyes, Shuwen He, Simon Mathieu, et al.
Page
of 107
Search research articles
Search
Showing results (1041-1050 of 1,063) with videos related to
Sort By:
Page
of 107
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity
Iyassu K Sebhat, Christopher Franklin, Michael M-C Lo, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 2, 2010
Antiobesity effect of MK-5046, a novel bombesin receptor subtype-3 agonist
Xiao-Ming Guan, Joseph M Metzger, Liming Yang, et al.
Archives of General Psychiatry
|
November 9, 2011
Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial
Roger D Weiss, Jennifer Sharpe Potter, David A Fiellin, et al.
Stem Cell Reports
|
November 10, 2015
Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem Cells
Zita Garate, Oscar Quintana-Bustamante, Ana M Crane, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 29, 2010
Biaryl substituted hydantoin compounds as TACE inhibitors
Wensheng Yu, Ling Tong, Seong Heon Kim, et al.
Plos One
|
October 21, 2017
GPR40 partial agonists and AgoPAMs: Differentiating effects on glucose and hormonal secretions in the rodent
Michele J Pachanski, Melissa E Kirkland, Daniel T Kosinski, et al.
American Journal of Obstetrics and Gynecology
|
June 5, 2021
Experience of 300 cases of prenatal fetoscopic open spina bifida repair: report of the International Fetoscopic Neural Tube Defect Repair Consortium
Magdalena Sanz Cortes, Ramen H Chmait, Denise A Lapa, et al.
Lancet (London, England)
|
March 24, 2009
Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials
Mark A Hlatky, Derek B Boothroyd, Dena M Bravata, et al.
JAMA Internal Medicine
|
April 13, 2026
Palliative Care Intervention for Patients With End-Stage Liver Disease: A Cluster Randomized Clinical Trial
Manisha Verma, Victor Navarro, Andrzej Kosinski, et al.
Journal of Medicinal Chemistry
|
July 25, 2025
Discovery of Gut-Targeted GPR40 Agonist K-757 and GPR119 Agonist K-833, a Combination Treatment for Metabolic Disorders
Christopher R Moyes, Shuwen He, Simon Mathieu, et al.
Page
of 107